Jing Rong Jean Cui
Fortune : 62 M $ au 31/07/2026
Fortune : 62 M $ au 31/07/2026
Dr. Jing Rong Jean Cui is a President, CEO, Director & Scientific Founder at Blossomhill Therapeutics, Inc. She is on the Board of Directors at Blossomhill Therapeutics, Inc. Dr. Jean Cui also served on the board at Turning Point Therapeutics, Inc. She received her undergraduate degree from the University of Science & Technology of China, a graduate degree from the University of Science & Technology of China and a doctorate degree from The Ohio State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/08/2026 | 3 973 138 ( 12,97 % ) | 62 M $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BLOSSOMHILL THERAPEUTICS, INC. | Fondateur | 01/06/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
| TURG POIN | Fondateur | 15/06/2020 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Turning Point Therapeutics, Inc.
Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Science & Technology of China
University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national